Agena Bioscience at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Agena Bioscience brings 4 presentations to AMP 2026 in Seattle, and exhibits at Booth 629. Its program centres on pharmacogenomics implementation, reference materials for genotyping, and laboratory payment policy. Sessions cover applying CPIC guidelines to NAT2, moving DPYD testing from guideline into routine practice, and a reference material for multiplexed genotyping of pharmacogenomic variants.
| Organization | AMP 2026 Attendance |
|---|---|
Agena Bioscience San Diego, CA | |
MassARRAY platform for targeted genomic analysis — mutation profiling, liquid biopsy and pharmacogenetics for research laboratories. | Booth Exhibiting at Booth 629 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Talk Tue, Nov 10 9:00am–4:30pm Workshop Wed, Nov 11 11:00am–11:50am NAT2 Pharmacogenomics: Applying CPIC Guidelines with CDC GeT-RM Reference Materials NAT2 acetylator genotyping: applying dosing guidelines and using CDC reference materials to validate the assay. Workshop Wed, Nov 11 12:00pm–12:50pm DPYD - From Guidelines to Implementation Testing DPYD variants before fluoropyrimidine chemotherapy: which variants to include, translating results to dose, and adoption barriers. Talk Fri, Nov 13 10:15am–11:45am |
Instantly find 20 buyers from Agena Bioscience
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction